Alcentra Capital (NASDAQ:ABDC) – Oppenheimer boosted their FY2018 earnings per share estimates for Alcentra Capital in a research note issued on Tuesday, May 8th. Oppenheimer analyst C. Kotowski now expects that the asset manager will earn $0.86 per share for the year, up from their previous estimate of $0.82.
Alcentra Capital (NASDAQ:ABDC) last posted its quarterly earnings data on Monday, May 7th. The asset manager reported $0.27 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.26 by $0.01. The firm had revenue of $8.18 million for the quarter, compared to the consensus estimate of $8.23 million. Alcentra Capital had a negative net margin of 51.32% and a positive return on equity of 10.44%.
A number of other research firms also recently issued reports on ABDC. ValuEngine downgraded shares of Alcentra Capital from a “hold” rating to a “sell” rating in a report on Wednesday, May 2nd. Keefe, Bruyette & Woods set a $7.00 price objective on shares of Alcentra Capital and gave the stock a “hold” rating in a report on Thursday, March 15th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $12.00.
Alcentra Capital opened at $6.39 on Friday, according to MarketBeat Ratings. The firm has a market cap of $87.88 million, a price-to-earnings ratio of 4.84 and a beta of 0.59. Alcentra Capital has a 1 year low of $6.38 and a 1 year high of $6.62.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 5th. Shareholders of record on Friday, June 29th will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 11.27%. The ex-dividend date is Thursday, June 28th. Alcentra Capital’s dividend payout ratio is 54.55%.
In other news, Director Edward Grebow acquired 5,000 shares of the business’s stock in a transaction on Thursday, May 10th. The shares were purchased at an average cost of $6.47 per share, with a total value of $32,350.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Branko Krmpotic acquired 10,000 shares of the business’s stock in a transaction on Tuesday, March 20th. The shares were purchased at an average cost of $6.15 per share, for a total transaction of $61,500.00. Following the completion of the acquisition, the insider now directly owns 14,000 shares in the company, valued at $86,100. The disclosure for this purchase can be found here. Insiders have acquired a total of 19,750 shares of company stock worth $124,138 over the last ninety days. Insiders own 4.96% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Stilwell Value LLC raised its stake in shares of Alcentra Capital by 20.7% during the 1st quarter. Stilwell Value LLC now owns 1,251,324 shares of the asset manager’s stock worth $8,709,000 after purchasing an additional 214,277 shares during the period. Pacific Ridge Capital Partners LLC raised its stake in shares of Alcentra Capital by 221.8% during the 1st quarter. Pacific Ridge Capital Partners LLC now owns 449,260 shares of the asset manager’s stock worth $3,127,000 after purchasing an additional 309,660 shares during the period. Salzhauer Michael raised its stake in shares of Alcentra Capital by 160.3% during the 1st quarter. Salzhauer Michael now owns 123,121 shares of the asset manager’s stock worth $857,000 after purchasing an additional 75,829 shares during the period. BlackRock Inc. raised its stake in shares of Alcentra Capital by 18.0% during the 4th quarter. BlackRock Inc. now owns 89,703 shares of the asset manager’s stock worth $753,000 after purchasing an additional 13,669 shares during the period. Finally, Wasatch Advisors Inc. raised its stake in shares of Alcentra Capital by 151.5% during the 4th quarter. Wasatch Advisors Inc. now owns 85,813 shares of the asset manager’s stock worth $720,000 after purchasing an additional 51,689 shares during the period. Institutional investors own 35.76% of the company’s stock.
Alcentra Capital Company Profile
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.